Director's Dealing • Apr 6, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6233V
Essentra plc
06 April 2023
Essentra plc (the "Company")
Director/PDMR Shareholding
The notification below, is made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.
Essentra plc announces that the following Directors and PDMRs of Essentra plc purchased ordinary shares in the Company on 4 and 5 April 2023.
No. of shares
Price
Paul Lester
Chair & Non-Executive Director
11,200
1.96428
Jack Clarke
Chief Financial Officer
13,500
1.94680
Mary Reilly
Non-Executive Director
2,000
1.93297
Ralf Wunderlich
Non-Executive Director
10,000
1.92
Adrian Peace
Non-Executive Director
2,000
1.92
Dupsy Abiola
Non-Executive Director
2,011
1.98288
Kath Durrant
Non-Executive Director
7,500
1.94598
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
| Paul Lester |
| Jack Clarke |
| Mary Reilly |
| Ralf Wunderlich |
| Adrian Peace |
| Dupsy Abiola |
| Kath Durrant |
2
Reason for the notification
a)
Position/status
| Paul Lester | Chair & Non-Executive Director |
| Jack Clarke | Chief Financial Officer |
| Mary Reilly | Non-Executive Director |
| Ralf Wunderlich | Non-Executive Director |
| Adrian Peace | Non-Executive Director |
| Dupsy Abiola | Non-Executive Director |
| Kath Durrant | Non-Executive Director |
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Essentra plc
b)
LEI
5493007MOZNA03BVNE96
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary 25p shares
Identification code
GB00B0744359
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
| Price (£) | Volume | |
| Paul Lester | 1.96428 | 11,200 |
| Jack Clarke | 1.9468 | 13,500 |
| Mary Reilly | 1.93297 | 2,000 |
| Ralf Wunderlich | 1.92 | 10,000 |
| Adrian Peace | 1.92 | 2,000 |
| Dupsy Abiola | 1.98288 | 2,011 |
| Kath Durrant | 1.94598 | 7,500 |
d)
Aggregated information
- Aggregated volume
- Aggregated Price
| Aggregated Volume | Aggregated Price £ | |
| Paul Lester | 11,200 | 21,999.94 |
| Jack Clarke | 13,500 | 26,281.80 |
| Mary Reilly | 2,000 | 3,865.94 |
| Ralf Wunderlich | 10,000 | 19,200.00 |
| Adrian Peace | 2,000 | 3,840.00 |
| Dupsy Abiola | 2,011 | 3,987.57 |
| Kath Durrant | 7,500 | 14,594.85 |
| Total | 48,211 | 93,770.10 |
e)
Date of the transaction
| Date of transaction | |
| Paul Lester | 5 April 2023 |
| Jack Clarke | 4 April 2023 |
| Mary Reilly | 4 April 2023 |
| Ralf Wunderlich | 4 April 2023 |
| Adrian Peace | 4 April 2023 |
| Dupsy Abiola | 4 April 2023 |
| Kath Durrant | 4 April 2023 |
f)
Place of the transaction
London Stock Exchange (XLON)
For futher enquiries, please contact
Essentra plc
Emma Reid
Company Secretay
T: + 44 (0) 1908 359100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUPURGCUPWUMQ
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.